Menu

Smartphone Diagnostic

Researchers design a device that attaches to a smartphone to test for diverse infectious diseases from a drop of blood.

Feb 5, 2015
Jef Akst

A smartphone dongle with a disposable microfluidic cassetteTASSANEEWAN LAKSANASOPINA push of a button vacuums up a drop of blood from a finger prick, and in just 15 minutes, the device can determine if a person is infected with any of a variety of infectious diseases. The new device, developed by Columbia University’s Samuel Sia and colleagues, is designed to be hooked up to a smartphone, which provides a power source and a display for the results. Published yesterday (February 4) in Science Translational Medicine, the technology is the latest effort in smartphone diagnostics, which could bring improved health care to underdeveloped parts of the world.

The new device, which costs just $34, functions by drawing the blood sample through tiny channels containing “detection zones” designed to find antibodies in the blood suggestive of a particular pathogen’s presence. In a field test held at three Rwandan community clinics, health care workers screened patients for HIV and syphilis with 96-percent accuracy. The team is now planning a larger trial, Science reported.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.